SlideShare a Scribd company logo
1 of 75
Download to read offline
1
ECE Module -8
Blood Glucose Regulation and
Diabetes Mellitus
Goal: The student must be able understand the
importance of blood glucose regulation and
metabolic derangements in diabetes mellitus,
rational and interpretation of biochemical tests
done in diagnosing a case of diabetes mellitus.
Expected Competency:
1. Discuss the mechanism and significance of
blood glucose regulation in health and disease.
2. Demonstrate the understanding of metabolic
derangements in diabetes mellitus
3. Explain the basis and rationale of biochemical
tests done in diabetes mellitus.
Objectives :
At the end of the ECE module, 1st MBBS student shall be
able to:
1. Describe the regulation of blood glucose
2. Discuss the pathophysiology and metabolic alterations in
Diabetes Mellitus
3. Discuss the Biochemical basis of Polyuria, Polydipsia, Polyphagia
and other clinical manifestations in Diabetes Mellitus.
4. Sate the reference range for RPG, FPG, PPPG, HbA1c
5. Define the terms normoglycemia, hyperglycaemia and
hypoglycaemia
6. Mention the different criteria for diagnosis of Diabetes Mellitus
as per American Diabetic Association (ADA) and World Health
Organization (WHO) criteria
7. Interpret the lab report of patients with diabetes
8. List the guidelines to collect blood sample for glucose estimation.
9. Discuss the role of HbA1c in management of diabetes mellitus
10. Describe the steps of use of glucometer to estimate blood
glucose level.
Learning Experience: Total 3 hours
1. Introduction and instruction to students - 20 minutes
2. Relevant Basic science content discussion - 60 minutes
3. Case discussion - 60 minutes
4. Summary & Conclusion - 20 minutes
5. Reflections - 20 minutes
 Glucometer
 Somatostatin
 HOMAIR
 Houssay
 eAG
 Nephrosclerosis
 Maillard
 Sorbitol
 Kussmaul
 Metabolic Syndrome
 Fructosamine
 Acorbose
 Incretins
 Sanger
 Somogyi
 Insulin
 Glucagon
 Impaired
 C-Peptide
 Glut
Diabetes Mellitus
 Diabetes = “siphon" or “running through”
Large urine volume.
 Mellitus = Sweet (glucose in urine).
CLASSIFICATION OF DIABETES
MELLITUS
1.Type 1 Diabetes Mellitus
• Immune mediated
• Idiopathic
2. Type 2 Diabetes Mellitus
• Insulin resistance with relative insulin deficiency.
• Insulin secretary defect with Insulin Resistance.
3. Gestational Diabetes Mellitus.
4. Latent Autoimmune Diabetes in Adults
(LADA)
5. Other specific types:
A. Genetic defects of β cell function:
Maturity-Onset Diabetes of Young [MODY]
B. Genetic defects in Insulin action:
a) Type A Insulin Resistance.
b) Lipodystrophy syndrome.
C. Endocrinopathies: Cushing’s disease, thyrotoxicosis,
acromegaly.
D. Diseases of exocrine pancreas: Pancreatitis,
pancreatectomy, neoplasia, cystic fibrosis and
hemochromatosis.
E. Drug induced: Pentamidine, nicotinic acid,
glucocorticoids, β-adrenergic agonists, β-blockers,
clozapine.
F. Infections: Congenital rubella, Cytomegalovirus,
Coxsackie’s.
G. Uncommon forms of immune mediated diabetes:
Stiff man syndrome, anti insulin receptor antibodies.
H. Genetic syndromes associated with diabetes
mellitus: Down’s syndrome, Klinefelter’s syndrome,
Turner’s syndrome, Wolfram syndrome.
Type II Diabetes Mellitus: 90-95%
The risk of developing Type 2 diabetes:
➢ Family history of diabetes (in particular parents
or siblings with diabetes)
➢ Obesity (BMI ≥ 25 kg/m²)
➢ Age ≥ 45 years
➢ Previously identified IFG or IGT
➢ Hypertension (≥ 140/90 mmHg in adults)
➢ HDL cholesterol level <35 mg/dl and/or a
Triglyceride level ≥250 mg/dl.
➢ Reduced physical activity
➢ History of gestational diabetes mellitus (GDM) or
delivery of babies >4 kg
Gestational Diabetes :
 Glucose intolerance.
 1% to 14% ------ Abnormal glucose tolerance.
 Risk factors
 6% to 62% ------ Type 2 Diabetes.
METABOLIC DERANGEMENTS IN
DIABETES MELLITUS
➢ CARBOHYDRATE METABOLISM
➢ LIPID METABOLISM
➢ PROTEIN METABOLISM
Diagnosis of DM
Immunological markers
Islet cell antibodies (ICAs) 75 to 85%
Auto-antibodies to insulin
(IAAs)
90% ------ before 5 years
40% ------ after 12 years
Auto-antibodies to glutamic acid
decarboxylase (GAD65)
60%
Auto-antibodies to tyrosine
phosphatases (IA-2 and IA-2ßA)
50%
Zinc transporter ZnT8 60 to 80%
Insulin secretion
 Fasting : 2 to 25μIU/ml
 Glucose challenge : 200μIU/ml
 Pulses.
Fasting hypoglycemia
Polycystic ovarian syndrome
Classification and prediction of DM
Optimal therapy for DM
Insulin resistance
Coronary artery diseases.
Assessment of β-cell activity
Proinsulin:
 Clinical utility:
◦ Diagnosis of β cell tumors
◦ Familial Hyperproinsulinemia
◦ Cross reactivity of insulin assay
 Healthy, fasting individual ----- 1.1-6.9 to 2.1-12.6pmol/l
 High concentration:
◦ Type 2 DM
◦ GDM
◦ Chronic renal failure
◦ Cirrhosis
◦ Hyperthyroidism
C- peptide:
1. Fasting hypoglycemia •β cell tumors
•Insulin injections
2. Insulin secretion •>1.8μg/l -----type 2 DM
•<0.5μg/l ----- type 1 DM
3. Monitoring therapy •Undetectable ---- radical
pancreatectomy
•Increased ----- Islet cell
transplantation.
Reference interval:
•Fasting : 0.78 – 1.89ng/ml
•After stimulation : 2.73 – 5.64 ng/ml
Estimation of Blood Glucose:
 Sample collection.
 FPG: ≥126mg/dl on two occasions
 PPPG
 RPG: >200mg/dl
Glycosuria
 Renal threshold for Glucose: 180 mg/dl
Glucose Tolerance Test (GTT):
◦ Oral Glucose tolerance test (OGTT)
◦ Intravenous Glucose tolerance test
◦ Corticosteroid stressed GTT
Oral Glucose Tolerance Test
 Indications:
◦ Diagnosis of Impaired Glucose Tolerance.
◦ Gestational DM
◦ Unexplained complications of DM with RPG <140mg/dl
◦ Population studies.
 Preparation of the patient
 Procedure
 Factors influencing OGTT
◦ Patient preparation.
◦ Administration of glucose.
◦ During the test.
 Contraindications
Intravenous Glucose Tolerance Test
 Indication: Malabsorbtion
 DOSAGE: 25gm/dl over 3min ± 15 sec.
 Blood samples for 1 hr at 10 min interval.
 K=70/ t1/2
 Normal : 1.5%
 Diabetes:< 1.0%
Corticosteroid Stressed GTT
 Cortisol ----100mg (8hr and 2hr) then Glucose
given orally
 Normal:
◦ <180mg/dl at 1 hr
◦ <160mg/dl at 2hr.
 High in pre-diabetics.
ABNORMAL GTT CURVE
 Impaired Glucose Tolerance (IGT)
 Impaired Fasting Glycemia (IFG)
 Alimentary Glucosuria
100 g load 75g load
Fasting 95mg/dl 95mg/dl
1 hour 180mg/dl 180mg/dl
2 hour 155mg/dl 155mg/dl
3 hour 140mg/dl
Glycated Hemoglobin:
 Glycated hemoglobin A: “HbA1”
◦ HbA1a: Fructose-1,6-diphosphate (HbA1a1) or glucose-6-
phosphate (HbA1a2) at N-terminus of β chain
◦ HbA1b: Pyruvate at N-terminus of β chain
◦ HbA1c: Glucose at N-terminus of β chain (>80% of
HbA1)
 Schiff base
 Amadori rearrangement.
 Specimen and storage
◦ Venous blood----- EDTA, oxalate and fluoride
◦ Stable at 4º C ----- 1 week
◦ -70º C ---- 18 months.
 Reference intervals:
◦ 4 to 6%
◦ 5.7 to 6.4% ----- high risk
◦ ≥6.5% ----- decision point
◦ Goal of treatment : <7% (<6.5%)
 Advantages
Mean plasma glucose
A1C (%) mg/dL mmol/L
6 126 7.0
7 154 8.6
8 183 10.2
9 212 11.8
10 240 13.4
11 269 14.9
12 298 16.5
Correlation of HbA1c with Average Glucose
Fructosamine
 Glycated albumin
 Advantage
 Conditions not useful
 Reference interval
◦ 205 to 285 μmol/l
◦ Corrected albumin --- 191 to 265 μmol/l
◦ Glycated albumin --- 11- 16%
Ketone bodies
 Monitoring:
◦ Type 1 DM
◦ Pregnancy with preexisting DM
◦ GDM
 Reference interval:
◦ Normal : 0.21 to 2.81 mg/dl
◦ DM : >20mg/dl
UrinaryAlbumin Excretion(UAE)
 Persistent proteinuria ---- ≥200μg/min
 Microalbuminuria ---- 20- 200μg/min(30-300mg/24h)
 Albumin to creatinine ratio
μg/min mg/24h Correctedurine
creatinine(mg/g)
Normal <20 <30 <30
Increased UAE 20-200 30-300 30-300
Clinical
albuminuria
>200 >300 >300
Other Laboratory tests
 Renal profile: Blood urea and serum creatinine
 Lipid profile
 Acid base status
 Serum electrolytes : Abnormalities related to
dehydration and therapy.
Self-monitoring of Blood Glucose
(Point Of Care Testing)
1.A patient arrived at the ED with a blood sugar
of 578,serum osmolarity of 300,pH of 7.3,
severe thirst, dehydration and confusion.The
patient is breathing rapidly and has a fruity
breath smell.This patient has symptoms of
a) Diabetic ketoacidosis
b) Hyperosmolar hyperglycemic non ketotic
coma
c) Hypoglycemia
d) Diabetic neuropathy
2.The nurse enters a patient’s room and sees the patient
breathing rapidly with a fruity breath smell.This is known
as
a) Trousseau’s
b) Cullen’s
c) Kussmaul’s
d) Bitot’s
3.The diabetic patient’s lab work comes back
with a pH of 7.4, serum blood sugar of 950,
serum osmolarity of 460,pCO2 of 35, HCO3 of
25.The patient is confused and dehydrated.This
patient is showing signs and symptoms of
a) Diabetic ketoacidosis
b) Hyperosmolar hyperglycemic non ketotic
coma
c) Hypoglycemia
d) Diabetic neuropathy
4.Ben comes into the ED with blurred vision. He
has polyuria and complains of pain in his legs.
Labs show that he has elevated insulin levels and
high triglyceride levels. Ben also complains of
always being thirsty.What type of diabetes does
ben have?
a) Diabetes I
b) Diabetes II
5.Diabetes mellitus is characterized by
hypoglycemia.
a) True
b) False
7.The hormone that is secreted by the
alpha cells of the pancreas that raises blood
glucose when levels are low is:
a) Glucagon
b) Epiniphrine
c) Insulin
d) Cortisol
8.Type 2 diabetes is characterized by:
a) . Insulin resistance.
b) Insulin lack
c) Beta cell destruction
d) None of the above
9.A 35 year old patient comes to your
clinic with newly diagnosed diabetes. Lab
tests reveal no C-peptide in her blood.
She has lost a lot of weight recently,
despite the fact that she has been eating a
lot.This patient has:
a) Adult-onset diabetes
b) GDM
c) Type 2 diabetes
d) Type 1 diabetes
10.Type 2 diabetes typically is diagnosed
at a young age.
a) true
b) false
11.Which of the following tissues requires
insulin for glucose entry into cells:
a) Muscle
b) Liver
c) Kidney tissue
d) Nervous tissue
12The renal threshold for
glucose is ___________ mg/dl.
a) 180
b) 120
c) 200
d) 140
14.Determination of glycosylated
hemoglobin is used for:
a) Assessing present glucose control
b) Assessing blood glucose control for the past 3
day
c) Assessing long-term( 2 - 4 months) blood
glucose control
d) Adjusting daily insulin doses
15.Insulin promotes all the following
except :
a) lipolysis
b) lipogenesis
c) protein synthesis
d) glucose entry into cells
16.Gestational diabetes increases a
woman's chance of developing
diabetes later in life.
a) true
b) false
17.Ketones are a metabolic
by-product of body protein
catabolism.
a) true
b) false
18.Factors that seem to play a role in
the development of type 2 diabetes
include:
a) Weight and heredity
b) liver disease
c) enzyme deficiencies
d) childhood illnesses
19. Which of the following is not a major
risk factor for type 2 diabetes mellitus?
a) Exposure to environmental pollutants
b) Hypertension
c) Family history of type 2 diabetes in a first-
degree relative
d) Age older than 45 years
Case 1:
Mr. Venkatesh, a 45 year old businessman was happy
that he had lost 4 kg weight in the last 2 months. He
felt that he was losing weight as he had started
drinking more water than usual though he kept
feeling hungry all the time. He was feeling tiered
throughout the day, he felt as he was getting up 2-3
times a night to urinate that was disturbed his sleep
and made him feel tired all through the day. His lab
investigations revealed following significant findings:
Laboratory Findings:
Fasting Plasma Glucose: 170 mg/dl
Urine Sugar: Absent
Postprandial Plasma Glucose: 240 mg/dl
Urine Sugar: +
Urine ketones: Absent
HbA1c: 7.9 %
a. Suggest the probable diagnosis? Why is
urine sugar absent in fasting sample?
b. Discuss the Biochemical basis of
Polyuria, Polydipsia and Polyphagia
c. Discuss the Renal Tubular Reabsorption
of Glucose
Case 2:
An 18-year-old male presented to emergency
department with the complaints of vomiting and
abdominal pain since 10 hours. He was diagnosed as
diabetic at 10 years of age. On examination, the
patient had rapid breathing and a fruity odour of
breath. His lab report is as follows,
Random Plasma Glucose:- 500 mg/dl Blood Urea:-
72 mg/dl
Serum Creatinine:- 2.5 mg/dl
Sodium:- 126 mmol/L
Potassium:- 6.3 mmol/L
Chloride:- 86 mmol/L
Bicarbonate: - 12 mmol/L
Urine examination:
 pH -5
 Urine Sugar- ++++
 Ketone Bodies- +++
a. Suggest the probable diagnosis? State the
Reference values of the parameters tested
b. Explain the biochemical basis for rapid
breathing and characteristic fruity odour
of breath
c. Blood sample for glucose estimation is
collected in Sodium fluoride tube – Justify
Case 3:
Mr. Arun, a 35-year-old male software engineer
sits in-front of computer for more than 10 hours
a day. A month ago when he got checked his
blood glucose level, for his surprise his glucose
levels were in the impaired range. He is obese,
his BMI is 37.2 kg/m2 and he is worried about
developing diabetes.
a. State the diagnostic criteria of ADA for
diagnosis of diabetes mellitus
b. Mention the indications for conduction of
Glucose tolerance test
c. What advice will you give him regarding life
style modification?
Case 4:
A 60-year-old female patient with a 8-year history of
T2DM presents with an HbA1c of 9.0% despite
receiving hypoglycaemic drugs for treatment. Her BMI
is 29 kg/m2. Renal function is near normal (estimated
glomerular filtration rate [eGFR] of 89 mL/min/1.73
m2). She has mild dyslipidemia controlled with a statin
and hypertension controlled with an angiotensin II
receptor blocker (blood pressure ≤140/90 mm Hg).
Urine analysis was positive for glucose but negative for
protein
a. What is HbA1c? and state its referenceinterval
b. What is microalbuminuria? Write its diagnostic
significance
c. What is estimated GFR? Grade the chronic kidney
failure based on the GFR
Formative assessment:
1. Illustrate the various factors maintaining the
blood glucose level
2. Explain the role of hormones in regulating the
blood glucose level
3. Discuss the metabolic derangement in Diabetes
Mellitus
4. Sate the reference range for RPG, FPG, PPPG,
HbA1c
5. State the Diagnostic Criteria of Diabetes Mellitus
based on American Diabetes Association (ADA)
6. Describe the initial laboratory evaluation of a
case of type 2 Diabetes Mellitus
7. Explain the role of HbA1c in monitoring of
diabetic patients
8. Explain the procedure and interpretation of
Glucose tolerance test with illustrations
Reflection:
 What happened? (What did you learn
from this experience)
 So what? (What are the applications of
this learning)
 What next? (What knowledge or skills
do you need to develop so that you can
handle this type of situation?
Diabetes Mellitus_230826_193537.pdf detail

More Related Content

Similar to Diabetes Mellitus_230826_193537.pdf detail

Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)Vikas Reddy
 
Pertemuan pertama DM.pdf
Pertemuan pertama DM.pdfPertemuan pertama DM.pdf
Pertemuan pertama DM.pdfYolandaOlivia4
 
Revise Family Case Presentation Final
Revise Family Case Presentation   FinalRevise Family Case Presentation   Final
Revise Family Case Presentation Finalliza mariposque
 
6th Upload on DPP4 Inhibitors
6th Upload on DPP4 Inhibitors6th Upload on DPP4 Inhibitors
6th Upload on DPP4 Inhibitorsdrmainuddin
 
Approch to a patient with acut comlications of dm
Approch to a patient  with acut comlications of dmApproch to a patient  with acut comlications of dm
Approch to a patient with acut comlications of dmsiifan23
 
Dr tasnim dm
Dr tasnim dmDr tasnim dm
Dr tasnim dmdr Tasnim
 
Diabetic keto acidosis
Diabetic keto acidosisDiabetic keto acidosis
Diabetic keto acidosisKumar Abhinav
 
Diabetes lecture fall 2014
Diabetes lecture fall 2014Diabetes lecture fall 2014
Diabetes lecture fall 2014Alex Murray
 
Diabetes lecture fall 2014
Diabetes lecture fall 2014Diabetes lecture fall 2014
Diabetes lecture fall 2014Alex Murray
 
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALIDDIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALIDRooma Khalid
 
Non-pharmacological Management of Diabetes Mellitus.pptx
Non-pharmacological Management of Diabetes Mellitus.pptxNon-pharmacological Management of Diabetes Mellitus.pptx
Non-pharmacological Management of Diabetes Mellitus.pptxSamson Ojedokun
 
Diabetes Mellitus
Diabetes Mellitus Diabetes Mellitus
Diabetes Mellitus Angel Belle
 

Similar to Diabetes Mellitus_230826_193537.pdf detail (20)

Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)Diabetes Mellitus(Past,Present and Future)
Diabetes Mellitus(Past,Present and Future)
 
Pertemuan pertama DM.pdf
Pertemuan pertama DM.pdfPertemuan pertama DM.pdf
Pertemuan pertama DM.pdf
 
Interpretation of ketoacidosis (dka) part 2
Interpretation of ketoacidosis (dka) part 2Interpretation of ketoacidosis (dka) part 2
Interpretation of ketoacidosis (dka) part 2
 
Type 2 dm
Type 2 dmType 2 dm
Type 2 dm
 
Diabetes Mellitus Type 2 - Pathology.pptx
Diabetes Mellitus Type 2 - Pathology.pptxDiabetes Mellitus Type 2 - Pathology.pptx
Diabetes Mellitus Type 2 - Pathology.pptx
 
Diabetes m.
Diabetes m.Diabetes m.
Diabetes m.
 
Revise Family Case Presentation Final
Revise Family Case Presentation   FinalRevise Family Case Presentation   Final
Revise Family Case Presentation Final
 
6th Upload on DPP4 Inhibitors
6th Upload on DPP4 Inhibitors6th Upload on DPP4 Inhibitors
6th Upload on DPP4 Inhibitors
 
Approch to a patient with acut comlications of dm
Approch to a patient  with acut comlications of dmApproch to a patient  with acut comlications of dm
Approch to a patient with acut comlications of dm
 
Dr tasnim dm
Dr tasnim dmDr tasnim dm
Dr tasnim dm
 
Diabetic keto acidosis
Diabetic keto acidosisDiabetic keto acidosis
Diabetic keto acidosis
 
Diabetes lecture fall 2014
Diabetes lecture fall 2014Diabetes lecture fall 2014
Diabetes lecture fall 2014
 
Diabetes lecture fall 2014
Diabetes lecture fall 2014Diabetes lecture fall 2014
Diabetes lecture fall 2014
 
3. DM.pptx
3. DM.pptx3. DM.pptx
3. DM.pptx
 
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALIDDIABETIC KETOACIDOSIS  PRESENTATION BY ROOMA KHALID
DIABETIC KETOACIDOSIS PRESENTATION BY ROOMA KHALID
 
Diabetes
DiabetesDiabetes
Diabetes
 
Diabetes
DiabetesDiabetes
Diabetes
 
DM Evfmergencies2.ppt
DM Evfmergencies2.pptDM Evfmergencies2.ppt
DM Evfmergencies2.ppt
 
Non-pharmacological Management of Diabetes Mellitus.pptx
Non-pharmacological Management of Diabetes Mellitus.pptxNon-pharmacological Management of Diabetes Mellitus.pptx
Non-pharmacological Management of Diabetes Mellitus.pptx
 
Diabetes Mellitus
Diabetes Mellitus Diabetes Mellitus
Diabetes Mellitus
 

More from OmpriyaS

Radiology and details about x-ray and its pictures
Radiology and details about x-ray and its picturesRadiology and details about x-ray and its pictures
Radiology and details about x-ray and its picturesOmpriyaS
 
Blood supply of brain and spinal cord.pdf
Blood supply of brain and spinal cord.pdfBlood supply of brain and spinal cord.pdf
Blood supply of brain and spinal cord.pdfOmpriyaS
 
development of heart and it’s clinical abnormal
development of heart and it’s clinical abnormaldevelopment of heart and it’s clinical abnormal
development of heart and it’s clinical abnormalOmpriyaS
 
Cerebrum and sulcus and gyri and their functional areas
Cerebrum and sulcus and gyri and their functional areasCerebrum and sulcus and gyri and their functional areas
Cerebrum and sulcus and gyri and their functional areasOmpriyaS
 
Iron metabolism.pdf
Iron metabolism.pdfIron metabolism.pdf
Iron metabolism.pdfOmpriyaS
 
eicosanoids and prostaglandins.pdf
eicosanoids and prostaglandins.pdfeicosanoids and prostaglandins.pdf
eicosanoids and prostaglandins.pdfOmpriyaS
 

More from OmpriyaS (6)

Radiology and details about x-ray and its pictures
Radiology and details about x-ray and its picturesRadiology and details about x-ray and its pictures
Radiology and details about x-ray and its pictures
 
Blood supply of brain and spinal cord.pdf
Blood supply of brain and spinal cord.pdfBlood supply of brain and spinal cord.pdf
Blood supply of brain and spinal cord.pdf
 
development of heart and it’s clinical abnormal
development of heart and it’s clinical abnormaldevelopment of heart and it’s clinical abnormal
development of heart and it’s clinical abnormal
 
Cerebrum and sulcus and gyri and their functional areas
Cerebrum and sulcus and gyri and their functional areasCerebrum and sulcus and gyri and their functional areas
Cerebrum and sulcus and gyri and their functional areas
 
Iron metabolism.pdf
Iron metabolism.pdfIron metabolism.pdf
Iron metabolism.pdf
 
eicosanoids and prostaglandins.pdf
eicosanoids and prostaglandins.pdfeicosanoids and prostaglandins.pdf
eicosanoids and prostaglandins.pdf
 

Recently uploaded

Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Celine George
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfakmcokerachita
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 

Recently uploaded (20)

Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
Incoming and Outgoing Shipments in 1 STEP Using Odoo 17
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdf
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
call girls in Kamla Market (DELHI) 🔝 >༒9953330565🔝 genuine Escort Service 🔝✔️✔️
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 

Diabetes Mellitus_230826_193537.pdf detail

  • 1. 1 ECE Module -8 Blood Glucose Regulation and Diabetes Mellitus
  • 2.
  • 3. Goal: The student must be able understand the importance of blood glucose regulation and metabolic derangements in diabetes mellitus, rational and interpretation of biochemical tests done in diagnosing a case of diabetes mellitus. Expected Competency: 1. Discuss the mechanism and significance of blood glucose regulation in health and disease. 2. Demonstrate the understanding of metabolic derangements in diabetes mellitus 3. Explain the basis and rationale of biochemical tests done in diabetes mellitus.
  • 4. Objectives : At the end of the ECE module, 1st MBBS student shall be able to: 1. Describe the regulation of blood glucose 2. Discuss the pathophysiology and metabolic alterations in Diabetes Mellitus 3. Discuss the Biochemical basis of Polyuria, Polydipsia, Polyphagia and other clinical manifestations in Diabetes Mellitus. 4. Sate the reference range for RPG, FPG, PPPG, HbA1c 5. Define the terms normoglycemia, hyperglycaemia and hypoglycaemia 6. Mention the different criteria for diagnosis of Diabetes Mellitus as per American Diabetic Association (ADA) and World Health Organization (WHO) criteria 7. Interpret the lab report of patients with diabetes 8. List the guidelines to collect blood sample for glucose estimation. 9. Discuss the role of HbA1c in management of diabetes mellitus 10. Describe the steps of use of glucometer to estimate blood glucose level.
  • 5. Learning Experience: Total 3 hours 1. Introduction and instruction to students - 20 minutes 2. Relevant Basic science content discussion - 60 minutes 3. Case discussion - 60 minutes 4. Summary & Conclusion - 20 minutes 5. Reflections - 20 minutes
  • 6.
  • 7.  Glucometer  Somatostatin  HOMAIR  Houssay  eAG  Nephrosclerosis  Maillard  Sorbitol  Kussmaul  Metabolic Syndrome  Fructosamine  Acorbose  Incretins  Sanger  Somogyi  Insulin  Glucagon  Impaired  C-Peptide  Glut
  • 8. Diabetes Mellitus  Diabetes = “siphon" or “running through” Large urine volume.  Mellitus = Sweet (glucose in urine).
  • 9.
  • 10. CLASSIFICATION OF DIABETES MELLITUS 1.Type 1 Diabetes Mellitus • Immune mediated • Idiopathic 2. Type 2 Diabetes Mellitus • Insulin resistance with relative insulin deficiency. • Insulin secretary defect with Insulin Resistance.
  • 11. 3. Gestational Diabetes Mellitus. 4. Latent Autoimmune Diabetes in Adults (LADA)
  • 12. 5. Other specific types: A. Genetic defects of β cell function: Maturity-Onset Diabetes of Young [MODY] B. Genetic defects in Insulin action: a) Type A Insulin Resistance. b) Lipodystrophy syndrome. C. Endocrinopathies: Cushing’s disease, thyrotoxicosis, acromegaly. D. Diseases of exocrine pancreas: Pancreatitis, pancreatectomy, neoplasia, cystic fibrosis and hemochromatosis.
  • 13. E. Drug induced: Pentamidine, nicotinic acid, glucocorticoids, β-adrenergic agonists, β-blockers, clozapine. F. Infections: Congenital rubella, Cytomegalovirus, Coxsackie’s. G. Uncommon forms of immune mediated diabetes: Stiff man syndrome, anti insulin receptor antibodies. H. Genetic syndromes associated with diabetes mellitus: Down’s syndrome, Klinefelter’s syndrome, Turner’s syndrome, Wolfram syndrome.
  • 14. Type II Diabetes Mellitus: 90-95%
  • 15. The risk of developing Type 2 diabetes: ➢ Family history of diabetes (in particular parents or siblings with diabetes) ➢ Obesity (BMI ≥ 25 kg/m²) ➢ Age ≥ 45 years ➢ Previously identified IFG or IGT
  • 16. ➢ Hypertension (≥ 140/90 mmHg in adults) ➢ HDL cholesterol level <35 mg/dl and/or a Triglyceride level ≥250 mg/dl. ➢ Reduced physical activity ➢ History of gestational diabetes mellitus (GDM) or delivery of babies >4 kg
  • 17.
  • 18. Gestational Diabetes :  Glucose intolerance.  1% to 14% ------ Abnormal glucose tolerance.  Risk factors  6% to 62% ------ Type 2 Diabetes.
  • 19.
  • 20.
  • 21. METABOLIC DERANGEMENTS IN DIABETES MELLITUS ➢ CARBOHYDRATE METABOLISM ➢ LIPID METABOLISM ➢ PROTEIN METABOLISM
  • 22.
  • 24. Immunological markers Islet cell antibodies (ICAs) 75 to 85% Auto-antibodies to insulin (IAAs) 90% ------ before 5 years 40% ------ after 12 years Auto-antibodies to glutamic acid decarboxylase (GAD65) 60% Auto-antibodies to tyrosine phosphatases (IA-2 and IA-2ßA) 50% Zinc transporter ZnT8 60 to 80%
  • 25. Insulin secretion  Fasting : 2 to 25μIU/ml  Glucose challenge : 200μIU/ml  Pulses. Fasting hypoglycemia Polycystic ovarian syndrome Classification and prediction of DM Optimal therapy for DM Insulin resistance Coronary artery diseases. Assessment of β-cell activity
  • 26. Proinsulin:  Clinical utility: ◦ Diagnosis of β cell tumors ◦ Familial Hyperproinsulinemia ◦ Cross reactivity of insulin assay  Healthy, fasting individual ----- 1.1-6.9 to 2.1-12.6pmol/l  High concentration: ◦ Type 2 DM ◦ GDM ◦ Chronic renal failure ◦ Cirrhosis ◦ Hyperthyroidism
  • 27. C- peptide: 1. Fasting hypoglycemia •β cell tumors •Insulin injections 2. Insulin secretion •>1.8μg/l -----type 2 DM •<0.5μg/l ----- type 1 DM 3. Monitoring therapy •Undetectable ---- radical pancreatectomy •Increased ----- Islet cell transplantation. Reference interval: •Fasting : 0.78 – 1.89ng/ml •After stimulation : 2.73 – 5.64 ng/ml
  • 28. Estimation of Blood Glucose:  Sample collection.  FPG: ≥126mg/dl on two occasions  PPPG  RPG: >200mg/dl Glycosuria  Renal threshold for Glucose: 180 mg/dl
  • 29. Glucose Tolerance Test (GTT): ◦ Oral Glucose tolerance test (OGTT) ◦ Intravenous Glucose tolerance test ◦ Corticosteroid stressed GTT
  • 30. Oral Glucose Tolerance Test  Indications: ◦ Diagnosis of Impaired Glucose Tolerance. ◦ Gestational DM ◦ Unexplained complications of DM with RPG <140mg/dl ◦ Population studies.  Preparation of the patient  Procedure
  • 31.  Factors influencing OGTT ◦ Patient preparation. ◦ Administration of glucose. ◦ During the test.  Contraindications
  • 32. Intravenous Glucose Tolerance Test  Indication: Malabsorbtion  DOSAGE: 25gm/dl over 3min ± 15 sec.  Blood samples for 1 hr at 10 min interval.  K=70/ t1/2  Normal : 1.5%  Diabetes:< 1.0%
  • 33. Corticosteroid Stressed GTT  Cortisol ----100mg (8hr and 2hr) then Glucose given orally  Normal: ◦ <180mg/dl at 1 hr ◦ <160mg/dl at 2hr.  High in pre-diabetics.
  • 34. ABNORMAL GTT CURVE  Impaired Glucose Tolerance (IGT)  Impaired Fasting Glycemia (IFG)  Alimentary Glucosuria
  • 35.
  • 36.
  • 37. 100 g load 75g load Fasting 95mg/dl 95mg/dl 1 hour 180mg/dl 180mg/dl 2 hour 155mg/dl 155mg/dl 3 hour 140mg/dl
  • 38. Glycated Hemoglobin:  Glycated hemoglobin A: “HbA1” ◦ HbA1a: Fructose-1,6-diphosphate (HbA1a1) or glucose-6- phosphate (HbA1a2) at N-terminus of β chain ◦ HbA1b: Pyruvate at N-terminus of β chain ◦ HbA1c: Glucose at N-terminus of β chain (>80% of HbA1)  Schiff base  Amadori rearrangement.
  • 39.  Specimen and storage ◦ Venous blood----- EDTA, oxalate and fluoride ◦ Stable at 4º C ----- 1 week ◦ -70º C ---- 18 months.  Reference intervals: ◦ 4 to 6% ◦ 5.7 to 6.4% ----- high risk ◦ ≥6.5% ----- decision point ◦ Goal of treatment : <7% (<6.5%)  Advantages
  • 40.
  • 41. Mean plasma glucose A1C (%) mg/dL mmol/L 6 126 7.0 7 154 8.6 8 183 10.2 9 212 11.8 10 240 13.4 11 269 14.9 12 298 16.5 Correlation of HbA1c with Average Glucose
  • 42. Fructosamine  Glycated albumin  Advantage  Conditions not useful  Reference interval ◦ 205 to 285 μmol/l ◦ Corrected albumin --- 191 to 265 μmol/l ◦ Glycated albumin --- 11- 16%
  • 43. Ketone bodies  Monitoring: ◦ Type 1 DM ◦ Pregnancy with preexisting DM ◦ GDM  Reference interval: ◦ Normal : 0.21 to 2.81 mg/dl ◦ DM : >20mg/dl
  • 44. UrinaryAlbumin Excretion(UAE)  Persistent proteinuria ---- ≥200μg/min  Microalbuminuria ---- 20- 200μg/min(30-300mg/24h)  Albumin to creatinine ratio μg/min mg/24h Correctedurine creatinine(mg/g) Normal <20 <30 <30 Increased UAE 20-200 30-300 30-300 Clinical albuminuria >200 >300 >300
  • 45. Other Laboratory tests  Renal profile: Blood urea and serum creatinine  Lipid profile  Acid base status  Serum electrolytes : Abnormalities related to dehydration and therapy.
  • 46.
  • 47.
  • 48. Self-monitoring of Blood Glucose (Point Of Care Testing)
  • 49.
  • 50. 1.A patient arrived at the ED with a blood sugar of 578,serum osmolarity of 300,pH of 7.3, severe thirst, dehydration and confusion.The patient is breathing rapidly and has a fruity breath smell.This patient has symptoms of a) Diabetic ketoacidosis b) Hyperosmolar hyperglycemic non ketotic coma c) Hypoglycemia d) Diabetic neuropathy
  • 51. 2.The nurse enters a patient’s room and sees the patient breathing rapidly with a fruity breath smell.This is known as a) Trousseau’s b) Cullen’s c) Kussmaul’s d) Bitot’s
  • 52. 3.The diabetic patient’s lab work comes back with a pH of 7.4, serum blood sugar of 950, serum osmolarity of 460,pCO2 of 35, HCO3 of 25.The patient is confused and dehydrated.This patient is showing signs and symptoms of a) Diabetic ketoacidosis b) Hyperosmolar hyperglycemic non ketotic coma c) Hypoglycemia d) Diabetic neuropathy
  • 53. 4.Ben comes into the ED with blurred vision. He has polyuria and complains of pain in his legs. Labs show that he has elevated insulin levels and high triglyceride levels. Ben also complains of always being thirsty.What type of diabetes does ben have? a) Diabetes I b) Diabetes II
  • 54. 5.Diabetes mellitus is characterized by hypoglycemia. a) True b) False
  • 55. 7.The hormone that is secreted by the alpha cells of the pancreas that raises blood glucose when levels are low is: a) Glucagon b) Epiniphrine c) Insulin d) Cortisol
  • 56. 8.Type 2 diabetes is characterized by: a) . Insulin resistance. b) Insulin lack c) Beta cell destruction d) None of the above
  • 57. 9.A 35 year old patient comes to your clinic with newly diagnosed diabetes. Lab tests reveal no C-peptide in her blood. She has lost a lot of weight recently, despite the fact that she has been eating a lot.This patient has: a) Adult-onset diabetes b) GDM c) Type 2 diabetes d) Type 1 diabetes
  • 58. 10.Type 2 diabetes typically is diagnosed at a young age. a) true b) false
  • 59. 11.Which of the following tissues requires insulin for glucose entry into cells: a) Muscle b) Liver c) Kidney tissue d) Nervous tissue
  • 60. 12The renal threshold for glucose is ___________ mg/dl. a) 180 b) 120 c) 200 d) 140
  • 61. 14.Determination of glycosylated hemoglobin is used for: a) Assessing present glucose control b) Assessing blood glucose control for the past 3 day c) Assessing long-term( 2 - 4 months) blood glucose control d) Adjusting daily insulin doses
  • 62. 15.Insulin promotes all the following except : a) lipolysis b) lipogenesis c) protein synthesis d) glucose entry into cells
  • 63. 16.Gestational diabetes increases a woman's chance of developing diabetes later in life. a) true b) false
  • 64. 17.Ketones are a metabolic by-product of body protein catabolism. a) true b) false
  • 65. 18.Factors that seem to play a role in the development of type 2 diabetes include: a) Weight and heredity b) liver disease c) enzyme deficiencies d) childhood illnesses
  • 66. 19. Which of the following is not a major risk factor for type 2 diabetes mellitus? a) Exposure to environmental pollutants b) Hypertension c) Family history of type 2 diabetes in a first- degree relative d) Age older than 45 years
  • 67. Case 1: Mr. Venkatesh, a 45 year old businessman was happy that he had lost 4 kg weight in the last 2 months. He felt that he was losing weight as he had started drinking more water than usual though he kept feeling hungry all the time. He was feeling tiered throughout the day, he felt as he was getting up 2-3 times a night to urinate that was disturbed his sleep and made him feel tired all through the day. His lab investigations revealed following significant findings: Laboratory Findings: Fasting Plasma Glucose: 170 mg/dl Urine Sugar: Absent Postprandial Plasma Glucose: 240 mg/dl Urine Sugar: + Urine ketones: Absent HbA1c: 7.9 %
  • 68. a. Suggest the probable diagnosis? Why is urine sugar absent in fasting sample? b. Discuss the Biochemical basis of Polyuria, Polydipsia and Polyphagia c. Discuss the Renal Tubular Reabsorption of Glucose
  • 69. Case 2: An 18-year-old male presented to emergency department with the complaints of vomiting and abdominal pain since 10 hours. He was diagnosed as diabetic at 10 years of age. On examination, the patient had rapid breathing and a fruity odour of breath. His lab report is as follows, Random Plasma Glucose:- 500 mg/dl Blood Urea:- 72 mg/dl Serum Creatinine:- 2.5 mg/dl Sodium:- 126 mmol/L Potassium:- 6.3 mmol/L Chloride:- 86 mmol/L Bicarbonate: - 12 mmol/L
  • 70. Urine examination:  pH -5  Urine Sugar- ++++  Ketone Bodies- +++ a. Suggest the probable diagnosis? State the Reference values of the parameters tested b. Explain the biochemical basis for rapid breathing and characteristic fruity odour of breath c. Blood sample for glucose estimation is collected in Sodium fluoride tube – Justify
  • 71. Case 3: Mr. Arun, a 35-year-old male software engineer sits in-front of computer for more than 10 hours a day. A month ago when he got checked his blood glucose level, for his surprise his glucose levels were in the impaired range. He is obese, his BMI is 37.2 kg/m2 and he is worried about developing diabetes. a. State the diagnostic criteria of ADA for diagnosis of diabetes mellitus b. Mention the indications for conduction of Glucose tolerance test c. What advice will you give him regarding life style modification?
  • 72. Case 4: A 60-year-old female patient with a 8-year history of T2DM presents with an HbA1c of 9.0% despite receiving hypoglycaemic drugs for treatment. Her BMI is 29 kg/m2. Renal function is near normal (estimated glomerular filtration rate [eGFR] of 89 mL/min/1.73 m2). She has mild dyslipidemia controlled with a statin and hypertension controlled with an angiotensin II receptor blocker (blood pressure ≤140/90 mm Hg). Urine analysis was positive for glucose but negative for protein a. What is HbA1c? and state its referenceinterval b. What is microalbuminuria? Write its diagnostic significance c. What is estimated GFR? Grade the chronic kidney failure based on the GFR
  • 73. Formative assessment: 1. Illustrate the various factors maintaining the blood glucose level 2. Explain the role of hormones in regulating the blood glucose level 3. Discuss the metabolic derangement in Diabetes Mellitus 4. Sate the reference range for RPG, FPG, PPPG, HbA1c 5. State the Diagnostic Criteria of Diabetes Mellitus based on American Diabetes Association (ADA) 6. Describe the initial laboratory evaluation of a case of type 2 Diabetes Mellitus 7. Explain the role of HbA1c in monitoring of diabetic patients 8. Explain the procedure and interpretation of Glucose tolerance test with illustrations
  • 74. Reflection:  What happened? (What did you learn from this experience)  So what? (What are the applications of this learning)  What next? (What knowledge or skills do you need to develop so that you can handle this type of situation?